Christine Chung, MD
Interventional Cardiology · Seattle, WANPI 1972866002
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (33.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Boston Scientific at 50.6% of the total. 2025 is the largest year on record at $80,126, 3.8 times the $20,964 reported in 2019. Among interventional cardiology clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 471 payments — averaging $444.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$106K
- Medtronic$45K
- Edwards Lifesciences$30K
- Abbott$20K
- Ancora Heart, Inc.$5K
- Philips North America LLC$1K
- plus $3K from 14 others
Across 11 payments — averaging $6112.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$62K
- Medtronic$5K
What the payments were for
- Consulting fees$70,56934%
- Speaking & faculty fees$65,98831%
- Grants$19,5009%
- Travel & lodging$34,15916%
- Food & beverage$19,3029%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 140 | $105,921 |
| Medtronic(2 entities) | 103 | $45,022 |
| Edwards Lifesciences | 84 | $29,736 |
| Abbott | 75 | $19,832 |
| Ancora Heart, Inc. | 19 | $4,861 |
| Philips North America LLC | 12 | $1,389 |
| Abiomed | 6 | $846 |
| Heartflow, Inc. | 4 | $499 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $293 |
| Shockwave Medical, Inc | 2 | $217 |
| Inari Medical, Inc. | 2 | $172 |
| AstraZeneca | 8 | $158 |
| Chiesi USA, Inc. | 1 | $145 |
| W. L. Gore & Associates, Inc. | 1 | $123 |
| Cardiva Medical, Inc. | 3 | $66 |
| Endologix LLC | 1 | $61 |
| Cardinal Health 200 LLC | 2 | $59 |
| Johnson & Johnson | 3 | $48 |
| Boehringer Ingelheim | 1 | $36 |
| Cardiovascular Systems Inc. | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$54,288
- COREVALVE EVOLUT R$21,576
- CoreValve Evolut$19,958
- SAPIEN 3 Ultra RESILIA$18,808
- WATCHMAN FLX$18,120
- VersaCross Access Solution$16,854
- NAVITOR$11,640
- Watchman$11,021
- AccuCinch$4,588
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$3,996
- TRICLIP$2,374
- AMPLATZER AMULET$2,214
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,935
- GENERAL - STRUCTURAL HEART$1,758
- Impella$678
- IGT Devices Und$643
- MitraClip System$527
- (9520) IGT Devices Undivided$487
- MitraClip$443
- SYNERGY$386
How this compares
$209,518 in reported general payments places this provider in the 90th percentile of 125 interventional cardiology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $9,438 |
| Atorvastatin Calcium | 13 | $81 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Seattle
- William LombardiSeattle$902K
- Kathleen KearneySeattle$448K
- Danny DvirSeattle$374K
- James McCabeSeattle$289K
- Christopher BrownSeattle$266K
- Lorenzo AzzaliniSeattle$233K
- Sidakpal PanaichSeattle$214K
- Sameer GafoorSeattle$80K
- Ravi HiraSeattle$64K
- Ming ZhangSeattle$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.